Quipt Home Medical Corp. (QIPT)
- Previous Close
2.1400 - Open
2.1400 - Bid 1.5400 x 200
- Ask 2.7600 x 200
- Day's Range
2.1400 - 2.1750 - 52 Week Range
1.8600 - 4.1700 - Volume
26,742 - Avg. Volume
130,961 - Market Cap (intraday)
93.293M - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.08
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
quipthomemedical.com1,200
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: QIPT
View MorePerformance Overview: QIPT
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QIPT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QIPT
View MoreValuation Measures
Market Cap
92.62M
Enterprise Value
177.89M
Trailing P/E
--
Forward P/E
212.77
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.37
Price/Book (mrq)
0.87
Enterprise Value/Revenue
0.73
Enterprise Value/EBITDA
3.11
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.60%
Return on Assets (ttm)
0.16%
Return on Equity (ttm)
-5.86%
Revenue (ttm)
244.72M
Net Income Avi to Common (ttm)
-6.36M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
15.45M
Total Debt/Equity (mrq)
94.82%
Levered Free Cash Flow (ttm)
29.28M